This Standard and Guidance identifies best practices and recommends guidelines for an effective insights management process.
Join the MAPS Med Tech FAWG as they discuss “Medical Affairs Mastery: Shaping the Future of MedTech with MAPS”!
Danie du Plessis, Chair of the MAPS Board of Directors, speaks with HSTalks about the MAPS organization and Medical Affairs leadership.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
This paper provides a vision describing how Gen AI technologies will reshape the possibilities and practice of Medical Affairs related to the four functional pillars of Strategy & Leadership, Evidence & Insights Generation, Evidence & Insights Communication, and Engagement & Partnerships.
In this on-demand webinar, learn how to develop robust strategic objectives, and why this is a skill that all Medical Affairs teams should possess.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity